中教控股(00839.HK)獲控股股東增持140萬股
格隆匯1月26日丨中教控股(00839.HK)公吿,公司接獲公司聯席主席兼執行董事於果和謝可滔通知,藍天教育國際有限公司和白雲教育國際有限公司於2022年1月26日在公開市場共購買140萬股公司股份,佔已發行股份總數約0.06%。
緊接增持股權後,藍天教育國際有限公司和白雲教育國際有限公司共持有15.014億股股份,佔已發行股份總數約62.84%。
於公吿日期,於果、謝可滔、藍天教育國際有限公司及白雲教育國際有限公司作為一致行動人士為公司控股股東。
於果及謝可滔對公司的前景充滿信心並考慮日後於適當時候進一步增持公司股權,惟須遵守適用法律及監管規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.